-- 
Sanofi-Aventis to Increase Insulin Output in Russia, IFX Says

-- B y   M a r i n a   S y s o y e v a
-- 
2011-03-23T12:01:50Z

-- http://www.bloomberg.com/news/2011-03-23/sanofi-aventis-to-increase-insulin-output-in-russia-ifx-says.html
Sanofi-Aventis SA (SAN)  plans to boost
output of insulin to full capacity at a Russian plant next year,
Interfax reported, citing Tatiana Galkova, the Paris-based
pharmaceutical company’s spokeswoman for  Russia .  ZAO Sanofi-Aventis Vostok, which is 51 percent owned by the
French company, plans to produce at least 15 million doses of
insulin at the plant in Orel in 2012 and may double capacity if
needed, Galkova said, according to Interfax.  Galkova couldn’t immediately be reached for comment by
Bloomberg News.  To contact the reporter on this story: Marina Sysoyeva in Moscow
at   msysoyeva@bloomberg.net   To contact the editor responsible for this story:
Claudia Carpenter at 
 ccarpenter2@bloomberg.net  